Actiferon SNDS Tablets: Slow release iron tablets, easy to swallow and easy on stomach.

Authors

  • Govind Shukla Lactonova Nutrition Research centre Hyderabad A unit of Lactonova Nutripharm (P) Ltd, Makers of Actiferon SNDS Tablets 81/3, IDA Mallapur, Hyderabad, Telangana, India-500 076.
  • C. Subrahmanyam Lactonova Nutrition Research centre Hyderabad A unit of Lactonova Nutripharm (P) Ltd, Makers of Actiferon SNDS Tablets 81/3, IDA Mallapur, Hyderabad, Telangana, India-500 076.
  • C.J Sampath Kumar Lactonova Nutrition Research centre Hyderabad A Unit of Lactonova Nutripharm (P) Ltd, 81/3, IDA Mallapur, Hyderabad, Telangana, India-500 076.

Keywords:

Actiferon SNDS Tablets, Anaemia, fatigue, exhaustion, weakness

Abstract

Actiferon SNDS Tablet is a dietary supplement, primarily used to manage anaemia caused due to low levels of Vitamin B12 and folic acid. Essential nutrients, responsible for the formation of red blood cells and helps in carrying oxygen throughout the body. It also helps in managing ailments associated with anaemia including fatigue, exhaustion and weakness. It is primarily used to manage anaemia caused due to low levels of Vitamin B12 and folic acid levels in the body. Supports the formation of healthy red blood cells which helps carry oxygen throughout the body and maintains cellular energy. Manages ailments associated with anaemia including fatigue and exhaustion. Helps maintain a healthy nervous system and manages ailments associated with diabetic neuropathies. The present paper Reviews the Role of Actiferon SNDS Tablets developed by R&D cell of Lactonova Nutripharm Pvt Ltd. Hyderabad in managing ailments associated with anaemia including fatigue, exhaustion and weakness.

Downloads

Published

2022-04-14

Issue

Vol. 8 No. 2 (2022): Vol 8, No. 2 (2022) 2022 Volume - 8 Issue-2

Section

Articles

License

Rights and reuse terms depend on the individual article record. Articles accepted on or after 8 September 2026 are licensed under Creative Commons Attribution 4.0 International (CC BY 4.0), provided appropriate credit is given, a link to the licence is supplied and changes are indicated. Earlier content remains governed by the rights and licence notice applicable to that article and is not retrospectively relicensed by this policy. Third-party material identified under a different notice is excluded from the journal licence.